SCHEMBL18103120

SCHEMBL18103120

COc1ccccc1/N=C(\OC(C)C)c1cc(C(=O)Nc2ccccc2OC)cc(/C(=N/c2ccccc2OC)OC(C)C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ HTT P42858 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ GRIN2D O15399 1/20 0.50
▸ GRIN3B O60391 1/20 0.50
▸ GRIN1 Q05586 1/20 0.50
▸ GRIN2A Q12879 1/20 0.50
▸ GRIN2B Q13224 1/20 0.50
▸ GRIN2C Q14957 1/20 0.50
▸ GRIN3A Q8TCU5 1/20 0.50
▸ SIGMAR1 Q99720 1/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ PABPC1 P11940 1/20 0.47
▸ APOBEC3A P31941 1/20 0.47
▸ EIF4H Q15056 1/20 0.47
▸ APOBEC3G Q9HC16 1/20 0.47
▸ MAPT P10636 1/20 0.46
▸ AHR P35869 1/20 0.46
▸ MLYCD O95822 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16681360 0.80 KMT2A (0.76) MEN1KMT2AHTTKDM4EPABPC1
SCHEMBL18100317 0.79 SIGMAR1 (0.39) MEN1KMT2AHTTGRIN2DGRIN3B
SCHEMBL18103144 0.78 SIRT2 (0.51) MEN1KMT2AHTTKDM4EGRIN2D
SCHEMBL5831957 0.75 KMT2A (0.64) MEN1KMT2AHTTKDM4ESMN1; SMN2
SCHEMBL13576585 0.72 PDE4D (0.76) MEN1KMT2AKDM4EMAPTAHR
SCHEMBL16677986 0.72 KCNK3 (0.64) MEN1KMT2AHTTKDM4ESMN1; SMN2
SCHEMBL18100388 0.72 MEN1 (0.50) MEN1KMT2ASMN1; SMN2MAPTAHR
SCHEMBL11797464 0.72 KMT2A (0.59) KMT2AHTTKDM4ESMN1; SMN2MAPT
SCHEMBL527994 0.71 RAB9A (0.77) MEN1KMT2AHTTKDM4EPABPC1
SCHEMBL29989592 0.71 RAB9A (0.77) MEN1KMT2AHTTKDM4EPABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2016-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE BRS3, RAD1, RAD51 MEN1 273/4885KMT2A 2801/4885HTT 4355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback